Matches in Wikidata for { <http://www.wikidata.org/entity/Q81636838> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q81636838 description "article scientifique publié en 2008" @default.
- Q81636838 description "artículu científicu espublizáu en xunetu de 2008" @default.
- Q81636838 description "scientific article published on 04 July 2008" @default.
- Q81636838 description "wetenschappelijk artikel" @default.
- Q81636838 description "наукова стаття, опублікована в липні 2008" @default.
- Q81636838 name "Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis" @default.
- Q81636838 name "Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis" @default.
- Q81636838 type Item @default.
- Q81636838 label "Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis" @default.
- Q81636838 label "Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis" @default.
- Q81636838 prefLabel "Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis" @default.
- Q81636838 prefLabel "Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis" @default.
- Q81636838 P1433 Q81636838-FAFB511C-8BE4-4520-B7A7-ED89558A499D @default.
- Q81636838 P1476 Q81636838-4A2E6A32-8C02-4B8F-9849-16E03B66D864 @default.
- Q81636838 P2093 Q81636838-39D34425-B752-4E03-AAFD-C6AB41256E06 @default.
- Q81636838 P2093 Q81636838-3A9F097F-6034-4AA0-AF2D-D055115161A6 @default.
- Q81636838 P2093 Q81636838-5F8A1E53-AB9D-4B25-896D-70432EC79887 @default.
- Q81636838 P2093 Q81636838-75774C32-E3FA-4C0F-ADFC-6C5BA2930472 @default.
- Q81636838 P2093 Q81636838-8EA33070-B430-4D0E-A935-143440CB7911 @default.
- Q81636838 P2093 Q81636838-BC46912D-34F7-424D-A358-D0B451E9E3A2 @default.
- Q81636838 P2093 Q81636838-E1CF8AC2-F4B7-4444-B9BF-EFB01E8DE959 @default.
- Q81636838 P2093 Q81636838-FE30F8E4-B97A-47BE-80ED-B37B9CBBB3E1 @default.
- Q81636838 P304 Q81636838-CDD57C58-A6EB-4A71-B7C9-78CAEEA2D3A7 @default.
- Q81636838 P31 Q81636838-132C75C9-5C6F-431A-AB6B-2E29E38127F2 @default.
- Q81636838 P356 Q81636838-A1C5A4E5-5409-4444-B2CB-AA06DE32BD4C @default.
- Q81636838 P433 Q81636838-2A5B98CE-ECA5-4A2D-B02E-DE0A98DC3437 @default.
- Q81636838 P478 Q81636838-2CB47594-F2EF-407B-B82E-15F25E54AA60 @default.
- Q81636838 P577 Q81636838-B16F34CA-71C0-44AA-BCE6-863E3261DBAF @default.
- Q81636838 P698 Q81636838-6EA193DE-7B95-4AB6-97E2-AEC2AF570232 @default.
- Q81636838 P356 J.1538-7836.2008.03063.X @default.
- Q81636838 P698 18624980 @default.
- Q81636838 P1433 Q6296004 @default.
- Q81636838 P1476 "Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis" @default.
- Q81636838 P2093 "C Mugford" @default.
- Q81636838 P2093 "D L Crandall" @default.
- Q81636838 P2093 "G A Morgan" @default.
- Q81636838 P2093 "G P Vlasuk" @default.
- Q81636838 P2093 "J K Hennan" @default.
- Q81636838 P2093 "R E Swillo" @default.
- Q81636838 P2093 "S J Gardell" @default.
- Q81636838 P2093 "T M Antrilli" @default.
- Q81636838 P304 "1558-1564" @default.
- Q81636838 P31 Q13442814 @default.
- Q81636838 P356 "10.1111/J.1538-7836.2008.03063.X" @default.
- Q81636838 P433 "9" @default.
- Q81636838 P478 "6" @default.
- Q81636838 P577 "2008-07-04T00:00:00Z" @default.
- Q81636838 P698 "18624980" @default.